| EER | ENST | ENSG | GeneName | Region | Repeat | dsRNA structure | | chr11:73879553-73881434:+ | ENST00000381783.4 | ENSG00000175575.11 | PAAF1 | ncRNA_exonic | (ATAT)n,AluSx1,AluJo,AluJb,AluYh3,AluJr,AluSq2,(CA)n | chr11:73879553-73881434:+.alignment |
| chr11:73882523-73886624:+ | ENST00000310571.6 | ENSG00000175575.11 | PAAF1 | intronic | L1MB7,L2c,AluY,L2,AluJr,AluJo,FLAM_C,AluSz6,AluSq2,AluSg,AluYa5 | chr11:73882523-73886624:+.alignment |
| chr11:73882523-73886624:+ | ENST00000504441.5 | ENSG00000175575.11 | PAAF1 | intronic | L1MB7,L2c,AluY,L2,AluJr,AluJo,FLAM_C,AluSz6,AluSq2,AluSg,AluYa5 | chr11:73882523-73886624:+.alignment |
| chr11:73882523-73886624:+ | ENST00000535604.4 | ENSG00000175575.11 | PAAF1 | intronic | L1MB7,L2c,AluY,L2,AluJr,AluJo,FLAM_C,AluSz6,AluSq2,AluSg,AluYa5 | chr11:73882523-73886624:+.alignment |
| chr11:73882523-73886624:+ | ENST00000536003.4 | ENSG00000175575.11 | PAAF1 | intronic | L1MB7,L2c,AluY,L2,AluJr,AluJo,FLAM_C,AluSz6,AluSq2,AluSg,AluYa5 | chr11:73882523-73886624:+.alignment |
| chr11:73882523-73886624:+ | ENST00000541951.4 | ENSG00000175575.11 | PAAF1 | intronic | L1MB7,L2c,AluY,L2,AluJr,AluJo,FLAM_C,AluSz6,AluSq2,AluSg,AluYa5 | chr11:73882523-73886624:+.alignment |
| chr11:73882523-73886624:+ | ENST00000542293.4 | ENSG00000175575.11 | PAAF1 | intronic | L1MB7,L2c,AluY,L2,AluJr,AluJo,FLAM_C,AluSz6,AluSq2,AluSg,AluYa5 | chr11:73882523-73886624:+.alignment |
| chr11:73882523-73886624:+ | ENST00000543814.4 | ENSG00000175575.11 | PAAF1 | intronic | L1MB7,L2c,AluY,L2,AluJr,AluJo,FLAM_C,AluSz6,AluSq2,AluSg,AluYa5 | chr11:73882523-73886624:+.alignment |
| chr11:73882523-73886624:+ | ENST00000544552.4 | ENSG00000175575.11 | PAAF1 | intronic | L1MB7,L2c,AluY,L2,AluJr,AluJo,FLAM_C,AluSz6,AluSq2,AluSg,AluYa5 | chr11:73882523-73886624:+.alignment |
| chr11:73882523-73886624:+ | ENST00000546039.4 | ENSG00000175575.11 | PAAF1 | intronic | L1MB7,L2c,AluY,L2,AluJr,AluJo,FLAM_C,AluSz6,AluSq2,AluSg,AluYa5 | chr11:73882523-73886624:+.alignment |
| chr11:73891619-73892251:+ | ENST00000543079.1 | ENSG00000175575.11 | PAAF1 | ncRNA_intronic | AluJr,AluJb | chr11:73891619-73892251:+.alignment |
| chr11:73929098-73930707:+ | ENST00000535936.1 | ENSG00000175575.11 | PAAF1 | ncRNA_exonic | AluY,AluSx1,AluSp,L1MA8,AluJb | chr11:73929098-73930707:+.alignment |
| ID_events | cancer | TypeID | ImmuneCell | P | R | CorrelationPlot |
| chr11:73929098-73930707:+ | BRCA | EER | T_cells_CD8 | 1.4695e-03 | -0.3024 |  |
| ENSG00000175575.11,PAAF1 | BRCA | EAG | Dendritic_cells_activated | 1.2871e-02 | 0.2246 |  |
| chr11:73879553-73881434:+ | ESCA | EER | B_cells_memory | 4.8498e-03 | 0.4653 |  |
| ENSG00000175575.11,PAAF1 | ESCA | EAG | Dendritic_cells_resting | 2.6595e-02 | -0.3342 |  |
| chr11:73879553-73881434:+ | GBM | EER | B_cells_memory | 4.3514e-03 | 0.5058 |  |
| chr11:73929098-73930707:+ | KIRC | EER | NK_cells_resting | 3.3171e-02 | 0.3558 |  |
| ENSG00000175575.11,PAAF1 | LAML | EAG | Mast_cells_resting | 2.0612e-02 | -0.2889 |  |
| chr11:73879553-73881434:+ | LGG | EER | Macrophages_M0 | 1.5228e-03 | 0.2636 |  |
| chr11:73882523-73886624:+ | LGG | EER | Mast_cells_activated | 3.7191e-02 | -0.1233 |  |
| ENSG00000175575.11,PAAF1 | LGG | EAG | Mast_cells_activated | 3.2387e-02 | -0.1200 |  |
| chr11:73879553-73881434:+ | OV | EER | T_cells_gamma_delta | 3.0665e-03 | 0.2750 |  |
| chr11:73882523-73886624:+ | OV | EER | Dendritic_cells_activated | 4.3349e-02 | 0.1930 |  |
| ENSG00000175575.11,PAAF1 | SKCM | EAG | Dendritic_cells_resting | 4.5602e-03 | 0.5289 |  |
| chr11:73879553-73881434:+ | STAD | EER | T_cells_regulatory_(Tregs) | 6.3416e-03 | -0.3327 | .chr11_73879553-73881434_+.png) |
| chr11:73882523-73886624:+ | STAD | EER | Macrophages_M2 | 1.5182e-03 | 0.4590 |  |
| ENSG00000175575.11,PAAF1 | STAD | EAG | Macrophages_M2 | 3.9050e-02 | 0.2067 |  |
| ENSG00000175575.11,PAAF1 | THCA | EAG | Mast_cells_resting | 2.1193e-02 | -0.3997 |  |
| ID_events | cancer | HallmarkType | Type | P | R | CorrelationPlot |
| ENSG00000175575.11,PAAF1 | BRCA | GSVA_HALLMARK_UV_RESPONSE_DN | EAG | 5.4793e-04 | 0.3084 |  |
| chr11:73929098-73930707:+ | BRCA | GSVA_HALLMARK_UV_RESPONSE_DN | EER | 8.3988e-03 | 0.2524 |  |
| ENSG00000175575.11,PAAF1 | ESCA | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EAG | 1.7283e-02 | 0.3572 |  |
| chr11:73879553-73881434:+ | ESCA | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EER | 9.5152e-03 | 0.4322 |  |
| ENSG00000175575.11,PAAF1 | GBM | GSVA_HALLMARK_ADIPOGENESIS | EAG | 2.4275e-04 | 0.4923 |  |
| chr11:73882523-73886624:+ | GBM | GSVA_HALLMARK_ADIPOGENESIS | EER | 6.7102e-03 | 0.3942 |  |
| chr11:73879553-73881434:+ | GBM | GSVA_HALLMARK_GLYCOLYSIS | EER | 8.7248e-05 | 0.6545 |  |
| chr11:73929098-73930707:+ | KIRC | GSVA_HALLMARK_MITOTIC_SPINDLE | EER | 2.1632e-02 | 0.3816 |  |
| chr11:73882523-73886624:+ | KIRC | GSVA_HALLMARK_HYPOXIA | EER | 4.5104e-02 | 0.3887 |  |
| ENSG00000175575.11,PAAF1 | LAML | GSVA_HALLMARK_NOTCH_SIGNALING | EAG | 4.2372e-03 | 0.3529 |  |
| chr11:73882523-73886624:+ | LGG | GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE | EER | 1.8142e-02 | 0.1396 |  |
| chr11:73879553-73881434:+ | LGG | GSVA_HALLMARK_SPERMATOGENESIS | EER | 2.4217e-02 | 0.1891 |  |
| ENSG00000175575.11,PAAF1 | LGG | GSVA_HALLMARK_ANDROGEN_RESPONSE | EAG | 1.3862e-03 | 0.1786 |  |
| ENSG00000175575.11,PAAF1 | LUAD | GSVA_HALLMARK_TNFA_SIGNALING_VIA_NFKB | EAG | 9.3253e-03 | 0.5298 |  |
| chr11:73882523-73886624:+ | OV | GSVA_HALLMARK_UV_RESPONSE_UP | EER | 1.5582e-04 | 0.3529 |  |
| chr11:73879553-73881434:+ | OV | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EER | 2.2117e-02 | 0.2142 |  |
| ENSG00000175575.11,PAAF1 | OV | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EAG | 1.9618e-04 | 0.2986 |  |
| ENSG00000175575.11,PAAF1 | SKCM | GSVA_HALLMARK_XENOBIOTIC_METABOLISM | EAG | 4.0161e-03 | 0.5352 |  |
| chr11:73882523-73886624:+ | STAD | GSVA_HALLMARK_XENOBIOTIC_METABOLISM | EER | 4.2044e-02 | -0.3044 |  |
| chr11:73879553-73881434:+ | STAD | GSVA_HALLMARK_P53_PATHWAY | EER | 3.3425e-02 | -0.2622 |  |
| ENSG00000175575.11,PAAF1 | THCA | GSVA_HALLMARK_DNA_REPAIR | EAG | 2.5391e-02 | 0.3887 |  |
| chr11:73929098-73930707:+ | THCA | GSVA_HALLMARK_APICAL_JUNCTION | EER | 3.7175e-02 | 0.3887 |  |
| ID_events | cancer | Drug | Type | P | R | CorrelationPlot |
| ENSG00000175575.11,PAAF1 | BRCA | EHT.1864 | EAG | 3.5150e-04 | 0.3184 |  |
| chr11:73929098-73930707:+ | BRCA | EHT.1864 | EER | 2.3087e-04 | 0.3473 |  |
| ENSG00000175575.11,PAAF1 | ESCA | AZD6244 | EAG | 4.0964e-03 | -0.4243 |  |
| chr11:73879553-73881434:+ | ESCA | AZD6244 | EER | 2.0981e-02 | -0.3888 |  |
| ENSG00000175575.11,PAAF1 | GBM | BIRB.0796 | EAG | 1.3905e-02 | 0.3424 |  |
| chr11:73882523-73886624:+ | GBM | Cyclopamine | EER | 1.5750e-03 | -0.4529 |  |
| chr11:73879553-73881434:+ | GBM | Imatinib | EER | 4.6287e-03 | 0.5028 |  |
| chr11:73929098-73930707:+ | KIRC | CHIR.99021 | EER | 2.0995e-02 | -0.3834 |  |
| chr11:73882523-73886624:+ | KIRC | Cytarabine | EER | 2.4861e-02 | 0.4308 |  |
| ENSG00000175575.11,PAAF1 | KIRC | AZD7762 | EAG | 4.5151e-02 | -0.2369 |  |
| ENSG00000175575.11,PAAF1 | LAML | ATRA | EAG | 2.5010e-02 | 0.2800 |  |
| chr11:73879553-73881434:+ | LGG | GNF.2 | EER | 9.3352e-03 | 0.2174 |  |
| ENSG00000175575.11,PAAF1 | LGG | DMOG | EAG | 1.8093e-02 | -0.1325 |  |
| ENSG00000175575.11,PAAF1 | LUAD | CHIR.99021 | EAG | 4.6534e-03 | -0.5684 |  |
| chr11:73882523-73886624:+ | OV | AKT.inhibitor.VIII | EER | 6.6060e-03 | 0.2575 |  |
| chr11:73879553-73881434:+ | OV | BAY.61.3606 | EER | 7.3169e-03 | 0.2500 |  |
| ENSG00000175575.11,PAAF1 | OV | MG.132 | EAG | 1.2496e-04 | -0.3081 |  |
| chr11:73929098-73930707:+ | OV | Bryostatin.1 | EER | 9.5454e-03 | -0.3562 |  |
| ENSG00000175575.11,PAAF1 | SKCM | AMG.706 | EAG | 2.3970e-03 | -0.5598 |  |
| chr11:73882523-73886624:+ | STAD | Cytarabine | EER | 6.2177e-04 | 0.4907 |  |
| chr11:73879553-73881434:+ | STAD | Cytarabine | EER | 3.1748e-02 | -0.2647 |  |
| ENSG00000175575.11,PAAF1 | STAD | CI.1040 | EAG | 2.0714e-02 | 0.2311 |  |
| chr11:73929098-73930707:+ | THCA | Axitinib | EER | 1.0323e-02 | 0.4687 |  |